The study probed the role of body weight on gut permeability and systemic inflammation and the impact on asthma control and asthma status.
Changes in gut function caused by weight gain are linked with an increase in asthma severity, according to a study presented this week in the United Kingdom.
It is already known that obesity worsens several chronic inflammatory diseases, perhaps as as gut-derived bacterial fragments (endotoxins) and associated markers of endotoxin (lipopolysaccharide binding protein [LPB]), enter the circulation through a damaged gut barrier, provoking systemic inflammation. The current study investigated the role of body weight on gut permeability and systemic inflammation and the impact on asthma control and asthma status.
The researchers examined the relationship between body weight and gut permeability with the symptoms of 98 patients with severe asthma, with and without obesity. All the patients were White, with 29 men and 69 women participating.
Patients with lean to obese body mass index (BMI) reported their symptoms using the Asthma Control Questionnaire-6.
Blood tests were taken to measure levels of gut permeability markers LPB and calprotectin, as well as markers of asthma-related inflammation (granzyme-A, interleukin [IL]-5, IL-6, CCL-4).
Patients with poorly controlled asthma had significantly higher levels of LBP and levels of LBP increased with increasing body weight. Increasing concentrations of LBP also correlated with higher levels of asthma-related inflammatory markers. Increased body weight was linked with higher levels of inflammation, signs of gut permeability, and poorer control of asthma.
The current study included only a small number of patients with severe, uncontrolled asthma, so the researchers plan to recruit more patients to the study and to investigate the effects in participants with well-controlled asthma, over a range of BMIs, as well as examining whether targeting the gut can improve asthma control in affected patients.
The findings highlight the gut as a potential, alternative therapeutic target for improving asthma control in patients with obesity.
“These data therefore suggest that reducing body weight, or therapeutically targeting the gut to reduce gut permeability, may offer people with obesity and severe asthma some improvement in their chronic inflammation conditions and disease management,” the researchers concluded.
The study was presented at the Society for Endocrinology annual conference.
Reference
Parenti C, Murphy AM, Lad N, et al. Investigating the effect of obesity on gut damage, systemic inflammation, enhanced asthma severity due to gut derived bacteria, endotoxin. Presented at: Society for Endocrinology Annual Conference; November 14-16, 2022; Harrowgate, England. Abstract P211.
Understanding the Unmet Need for Therapies to Treat Rare Bile Duct Cancer
May 24th 2022On this episode of Managed Care Cast, we bring you an excerpt of an interview with a co-chair of the 2022 Cholangiocarcinoma Foundation (CCF) annual conference, held earlier this year, about the significant unmet therapy needs facing most patients with this rare cancer.
Listen
Bimekizumab-bkzx, the Newest Psoriasis Treatment, Is Now Available
November 30th 2023Bimekizumab-bkzx (Bimzelx) is the first dual interleukin 17A (IL-17A) and interleukin 17F (IL-17F) inhibitor to treat moderate-to-severe plaque psoriasis. It launches with a list price of $7200 per syringe.
Read More
Study Finds ASCT Similarly Safe, Effective in Older and Younger Patients With Multiple Myeloma
November 30th 2023A real-world study suggests high-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is feasible for appropriately selected elderly patients, with similar results seen in older and younger patients.
Read More